- Home
- ATSG vs MDXG Comparison
ATSG vs MDXG Comparison
Compare ATSG & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATSG
- MDXG
- Stock Information
- Founded
- ATSG 1980
- MDXG 2006
- Country
- ATSG United States
- MDXG United States
- Employees
- ATSG N/A
- MDXG N/A
- Industry
- ATSG Air Freight/Delivery Services
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- ATSG Consumer Discretionary
- MDXG Health Care
- Exchange
- ATSG Nasdaq
- MDXG Nasdaq
- Market Cap
- ATSG 1.5B
- MDXG 1.3B
- IPO Year
- ATSG N/A
- MDXG N/A
- Fundamental
- Price
- ATSG $22.30
- MDXG $7.98
- Analyst Decision
- ATSG Buy
- MDXG Strong Buy
- Analyst Count
- ATSG 5
- MDXG 5
- Target Price
- ATSG $20.60
- MDXG $12.00
- AVG Volume (30 Days)
- ATSG 1.1M
- MDXG 518.6K
- Earning Date
- ATSG 03-04-2025
- MDXG 02-26-2025
- Dividend Yield
- ATSG N/A
- MDXG N/A
- EPS Growth
- ATSG N/A
- MDXG N/A
- EPS
- ATSG N/A
- MDXG 0.52
- Revenue
- ATSG $1,962,220,000.00
- MDXG $342,804,000.00
- Revenue This Year
- ATSG N/A
- MDXG $9.56
- Revenue Next Year
- ATSG $4.58
- MDXG $9.19
- P/E Ratio
- ATSG N/A
- MDXG $15.86
- Revenue Growth
- ATSG N/A
- MDXG 10.93
- 52 Week Low
- ATSG $11.62
- MDXG $5.47
- 52 Week High
- ATSG $22.35
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- ATSG 64.79
- MDXG 35.32
- Support Level
- ATSG $22.24
- MDXG $7.81
- Resistance Level
- ATSG $22.34
- MDXG $8.54
- Average True Range (ATR)
- ATSG 0.06
- MDXG 0.23
- MACD
- ATSG -0.01
- MDXG -0.05
- Stochastic Oscillator
- ATSG 78.26
- MDXG 18.09
About ATSG Air Transport Services Group Inc
Air Transport Services Group Inc along with its subsidiaries operates within the airfreight and logistics industry. It leases aircraft and provides airline operations, ground services, aircraft modification and maintenance, and other support services mainly to the cargo transportation and package delivery industries. The company has two reportable segments namely Cargo Aircraft Management and ACMI Services (Aircraft, Crew, Maintenance, and Insurance). It generates a majority of its revenue from the ACMI services segment.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.